Brain Cancer News and Research

RSS
There are two main types of brain cancer. Primary brain cancer starts in the brain. Metastatic brain cancer starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Also called glioma, meningioma.
Study reveals how aberrant epigenetic regulation contributes to aggressive pediatric brain tumors

Study reveals how aberrant epigenetic regulation contributes to aggressive pediatric brain tumors

Leveraging cancer therapies to combat tuberculosis

Leveraging cancer therapies to combat tuberculosis

Advanced laser imaging illuminates molecular interactions driving lung cancer growth

Advanced laser imaging illuminates molecular interactions driving lung cancer growth

Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth

Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth

Novel CAR-T therapy shows promising results in glioblastoma patients

Novel CAR-T therapy shows promising results in glioblastoma patients

Targeting a non-encoding stretch of RNA may shrink pediatric brain tumors in mice

Targeting a non-encoding stretch of RNA may shrink pediatric brain tumors in mice

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

AI method can predict brain metastasis in lung cancer patients

AI method can predict brain metastasis in lung cancer patients

Zika virus live-attenuated vaccine strains show promise in brain cancer treatment

Zika virus live-attenuated vaccine strains show promise in brain cancer treatment

Breakthrough nanopipette enables real-time observation of cancer cell reactions to treatment

Breakthrough nanopipette enables real-time observation of cancer cell reactions to treatment

Universal, essential biomarker identified for childhood neuroblastoma

Universal, essential biomarker identified for childhood neuroblastoma

Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Breakthrough research on glioma progression wins BIAL Award in Biomedicine

Breakthrough research on glioma progression wins BIAL Award in Biomedicine

Husker research duo selected as Phase 1 winners in the NIH's Targeted Genome Editor Delivery Challenge

Husker research duo selected as Phase 1 winners in the NIH's Targeted Genome Editor Delivery Challenge

MSU scientists unveil a potential game-changer in the fight against glioblastoma

MSU scientists unveil a potential game-changer in the fight against glioblastoma

New microscopy technology unveils detailed images of brain cancer tissue

New microscopy technology unveils detailed images of brain cancer tissue

Study paves the way for improving personalized treatment of patients with glioblastoma

Study paves the way for improving personalized treatment of patients with glioblastoma

AI can predict short-term and long-term survivors of brain cancer

AI can predict short-term and long-term survivors of brain cancer

Unintentional weight loss linked to increased risk of cancer diagnosis

Unintentional weight loss linked to increased risk of cancer diagnosis

Revolutionary brain scan lights up glioma's Achilles heel

Revolutionary brain scan lights up glioma's Achilles heel

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.